EP4180424
SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
9.3.2015:
25.6.2025:
22191079.7
:
8.3.2035:
8.3.2026
:
SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
9.3.2015
25.6.2025
8.3.2026
:
BioCryst Pharmaceuticals, Inc.:
4505 Emperor Blvd., Durham, NC 27703, US
:
KOTIAN, Pravin L.:
Hoover, 35226, US
:
BABU, Yarlagadda S.:
Birmingham, 35244, US
:
WU, Minwan:
Vestavia Hills, 35226, US
:
KUMAR, Satish V:
Birmingham, 35244, US
:
ZHANG, Weihe:
Vestavia, 35226, US
:
CHINTAREDDY, Venkat R:
Vestavia Hills, 35216, US
:
201461949808 P:
7.3.2014:
US
:
201461981515 P:
18.4.2014:
US
:
C07D 403/04, C07D 403/14, A61P 1/02, C07D 231/14, A61P 1/04, A61P 3/10, A61P 7/00, A61P 9/00, A61P 11/04, A61P 13/02, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12